Notably, one prior study suggested that mutations in TP53, PIK3CA, KMT2C, KMT2D, RB1, FAT4, NF1, CDKN2A, and CTNNB1 are driver mutations of anal cancer development.25 We identified several patients with tumor tissue containing mutations in these genes. Here, TP53 is linked to neoplasm.